Bacterin To Present at the 27th Annual Roth Conference BELGRADE, MT

Bacterin To Present at

the 27th Annual Roth

BELGRADE, MT, February 24, 2015 -- Bacterin International

Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts, today announced that its CEO, Dan Goldberger,

will present at the 2015 27th Annual Roth Conference to be held March 8th - 11th at The Ritz Carlton, Laguna Niguel, CA. Bacterin's

presentation will take place Wednesday, March 11, 2015 at 12:30 PM PT.

A live broadcast of the conference presentation will be available.

To access the broadcast, go to the "Investor Info" section of the Company's website at www.bacterin.com. A replay of

the conference presentation will also be available.

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops,

manufactures and markets biologics products to domestic and international markets. These products are used in a variety of applications

including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion

of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

For further information, please visit www.bacterin.com.

Important Cautions Regarding Forward-looking Statements

The presentation may contain forward-looking statements within

the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking

statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that

include words such as "continue," "efforts," "expects," "anticipates," "intends,"

"plans," "believes," "estimates," "projects," "forecasts," "strategy,"

"will," "goal," "target," "prospects," "potential," "optimistic," "confident,"

"likely," "probable" or similar expressions or the negative thereof. Statements of historical fact also may

be deemed to be forward- looking statements. We caution that these statements by their nature involve risks and uncertainties,

and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability

to meet its existing and anticipated contractual obligations, including financial covenant and other obligations contained in the

Company's secured lending facility; the Company's ability to manage cash flow and achieve profitability; the Company's ability

to remain listed on the NYSE MKT; the Company's ability to develop, market, sell and distribute desirable applications, products

and services and to protect its intellectual property; the ability of the Company's sales force to achieve expected results; the

ability of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as and

when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees

with appropriate skills and expertise; the Company's ability to successfully conclude government investigations; the impact of

changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors;

and other factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form

10-Q under the heading "Risk Factors." The Company undertakes no obligation to release publicly any revisions to any

forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated

events, except as required by law.